12 research outputs found
Recommended from our members
The Military and Political Career of Santos Degollado, 1854-1861
The purpose of this study is to examine the role of Santos Degollado in the history of Mexico during the 1850's and to determine his contributions to the cause of constitutional reform in that period
Near-Cloud Atmospheric Ingredients for Deep Convection Initiation
A lack of routine environmental observations located near deepening cumulus congestus clouds limits verification of important theorized and simulated updraftâenvironment interaction processes occurring during deep convection initiation (CI). We analyze radiosonde profiles collected during several hundred CI events near a mountain range in central Argentina during the CACTI field campaign. Statistical analyses illustrate environmental conditions supporting radar-observed CI outcomes that span a spectrum of convective cell depths, widths, and durations, as well as events lacking precipitating convection. Tested environmental factors include a large variety of sounding-derived measurements of CAPE, CIN, moisture, terrain-relative winds, vertical shear, and lifted parcel properties, with supplemental model reanalysis of background larger-scale vertical motion. CAPE and CIN metrics do not consistently differentiate CI success from failure. Only a few environmental factors contain consistent monotonic relationships among the spectrum of cloud depths achieved during CI: (i) the depth and strength of background ascent, and (ii) the component of low-level flow oriented parallel to the ridgeline. These metrics suggest that the ability of the surrounding flow to lift parcels to their LFC and terrain-modified flow are consistently relevant processes for CI. Low- to midlevel relative humidity strongly discriminated between CI and non-CI events, likely reflecting entrainment-driven dilution processes. However, we could not confidently conclude that relative humidity similarly discriminated robust from marginal CI events. Circumstantial evidence was found linking cell width, an important cloud property governing the probability of CI, to LCL height, boundary layer depth, depth and magnitude of the CIN layer, and ambient wind shear
LEMUR: Large European Module for solar Ultraviolet Research. European contribution to JAXA's Solar-C mission
Understanding the solar outer atmosphere requires concerted, simultaneous
solar observations from the visible to the vacuum ultraviolet (VUV) and soft
X-rays, at high spatial resolution (between 0.1" and 0.3"), at high temporal
resolution (on the order of 10 s, i.e., the time scale of chromospheric
dynamics), with a wide temperature coverage (0.01 MK to 20 MK, from the
chromosphere to the flaring corona), and the capability of measuring magnetic
fields through spectropolarimetry at visible and near-infrared wavelengths.
Simultaneous spectroscopic measurements sampling the entire temperature range
are particularly important.
These requirements are fulfilled by the Japanese Solar-C mission (Plan B),
composed of a spacecraft in a geosynchronous orbit with a payload providing a
significant improvement of imaging and spectropolarimetric capabilities in the
UV, visible, and near-infrared with respect to what is available today and
foreseen in the near future.
The Large European Module for solar Ultraviolet Research (LEMUR), described
in this paper, is a large VUV telescope feeding a scientific payload of
high-resolution imaging spectrographs and cameras. LEMUR consists of two major
components: a VUV solar telescope with a 30 cm diameter mirror and a focal
length of 3.6 m, and a focal-plane package composed of VUV spectrometers
covering six carefully chosen wavelength ranges between 17 and 127 nm. The
LEMUR slit covers 280" on the Sun with 0.14" per pixel sampling. In addition,
LEMUR is capable of measuring mass flows velocities (line shifts) down to 2
km/s or better.
LEMUR has been proposed to ESA as the European contribution to the Solar C
mission.Comment: 35 pages, 14 figures. To appear on Experimental Astronom
LEMUR: Large European Module for Solar Ultraviolet Research
The solar outer atmosphere is an extremely dynamic environment characterized by the continuous interplay between the plasma and the magnetic field that generates and permeates it. Such interactions play a fundamental role in hugely diverse astrophysical systems, but occur at scales that cannot be studied outside the solar system. Understanding this complex system requires concerted, simultaneous solar observations from the visible to the vacuum ultraviolet (VUV) and soft X-rays, at high spatial resolution (between 0.1 and 0.3), at high temporal resolution (on the order of 10 s, i.e., the time scale of chromospheric dynamics), with a wide temperature coverage (0.01 MK to 20 MK, from the chromosphere to the flaring corona), and the capability of measuring magnetic fields through spectropolarimetry at visible and near-infrared wavelengths. Simultaneous spectroscopic measurements sampling the entire temperature range are particularly important. These requirements are fulfilled by the Japanese Solar-C mission (Plan B), composed of a spacecraft in a geosynchronous orbit with a payload providing a significant improvement of imaging and spectropolarimetric capabilities in the UV, visible, and near-infrared with respect to what is available today and foreseen in the near future. The Large European Module for solar Ultraviolet Research (LEMUR), described in this paper, is a large VUV telescope feeding a scientific payload of high-resolution imaging spectrographs and cameras. LEMUR consists of two major components: a VUV solar telescope with a 30 cm diameter mirror and a focal length of 3.6 m, and a focal-plane package composed of VUV spectrometers covering six carefully chosen wavelength ranges between 170 Angstrom and 1270 Angstrom. The LEMUR slit covers 280 on the Sun with 0.14 per pixel sampling. In addition, LEMUR is capable of measuring mass flows velocities (line shifts) down to 2 km s 1 or better. LEMUR has been proposed to ESA as the European contribution to the Solar C mission
Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11-16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures
Recommended from our members
Santos Degollado and the Mexican Reforma, 1854-1861
This study examines in detail the public career of Santos Degollado during the era of the Mexican Reforma, and, because of his central role in national events of that period, the story is presented in the context of a general history of the Reforma. Sources of information were largely primary, including manuscripts and newspapers from Mexican archives. The richest of these were the collection of Degollado's letters at the Instituto de Antropologia e Historia; manuscripts from the Secretaria de Relaciones Exteriores archive, the Archivo Juarez of the Biblioteca Nacional, and the Centro de Estudios de Historia de Mexico; as well as documents from various collections at the University of Texas Latin American Collection. Important published sources included the 36-volume collection edited by Genaro Garcia and the 15 volumes of Benito Juarez papers edited by Jorge L. Tamayo. In seeking to explain and justify aspects of Degollado's conduct and behavior which have heretofore often been characterized as aberrations, this study has suggested some revised interpretation of the role of Benito Juarez in the Reforma. This great Mexican hero of the nineteenth century has long overshadowed the other important figures of the period, including Degollado. This study contends that not only should other Mexicans receive a larger share of credit for the progressive advances made during the Reforma, but also that Juarez should receive less
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
International audienceBackground: Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary syndromes. The factor Xa inhibitor rivaroxaban reduced mortality and ischaemic events when added to DAPT, but caused increased bleeding. The safety of a dual pathway antithrombotic therapy approach combining low-dose rivaroxaban (in place of aspirin) with a P2Y12 inhibitor has not been assesssed in acute coronary syndromes. We aimed to assess rivaroxaban 2·5 mg twice daily versus aspirin 100 mg daily, in addition to clopidogrel or ticagrelor (chosen at investigator discretion before randomisation), for patients with acute coronary syndromes started within 10 days after presentation and continued for 6-12 months.Methods: In this double-blind, multicentre, randomised trial (GEMINI-ACS-1) done at 371 clinical centres in 21 countries, eligible patients were older than 18 years with unstable angina, non-ST segment elevation myocardial infarction (NSTEMI) or ST segment elevation myocardial infarction (STEMI), with positive cardiac biomarkers and either ischaemic electrocardiographic changes or an atherosclerotic culprit lesion identified during angiography. Participants were randomly assigned (1:1) within 10 days after admission for the index acute coronary syndromes event to either aspirin or rivaroxaban based on a computer-generated randomisation schedule. Randomisation was balanced by using randomly permuted blocks with size of four and was stratified based on the background P2Y12 inhibitor (clopidogrel or ticagrelor) intended to be used at the time of randomisation. Investigators and patients were masked to treatment assignment. Patients received a minimum of 180 days of double-blind treatment with rivaroxaban 2·5 mg twice daily or aspirin 100 mg daily. The choice of clopidogrel or ticagrelor during trial conduct was not randomised and was based on investigator preference. The primary endpoint was thrombolysis in myocardial infarction (TIMI) clinically significant bleeding not related to coronary artery bypass grafting (CABG; major, minor, or requiring medical attention) up to day 390. Primary analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT02293395.Findings: Between April 22, 2015, and Oct 14, 2016, 3037 patients with acute coronary syndromes were randomly assigned; 1518 to receive aspirin and 1519 to receive rivaroxaban. 1704 patients (56%) were in the ticagrelor and 1333 (44%) in the clopidogrel strata. Median duration of treatment was 291 days (IQR 239-354). TIMI non-CABG clinically significant bleeding was similar with rivaroxaban versus aspirin therapy (total 154 patients [5%]; 80 participants [5%] of 1519 vs 74 participants [5%] of 1518; HR 1·09 [95% CI 0·80-1·50]; p=0·5840).Interpretation: A dual pathway antithrombotic therapy approach combining low-dose rivaroxaban with a P2Y12 inhibitor for the treatment of patients with acute coronary syndromes had similar risk of clinically significant bleeding as aspirin and a P2Y12 inhibitor. A larger, adequately powered trial would be required to definitively assess the efficacy and safety of this approach.Funding: Janssen Research & Development and Bayer AG
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection
BACKGROUND & AIMS: Most patients with Crohn\u2019s disease
(CD) eventually require an intestinal resection. However, CD
frequently recurs after resection. We performed a randomized
trial to compare the ability of infliximab vs placebo to prevent
CD recurrence. METHODS: We evaluated the efficacy of
infliximab in preventing postoperative recurrence of CD in
297 patients at 104 sites worldwide from November 2010
through May 2012. All study patients had undergone ileocolonic
resection within 45 days before randomization. Patients
were randomly assigned (1:1) to groups given infliximab
(5 mg/kg) or placebo every 8 weeks for 200 weeks. The
primary end point was clinical recurrence, defined as a
composite outcome consisting of a CD Activity Index score
>200 and a 70-point increase from baseline, and endoscopic
recurrence (Rutgeerts score i2, determined by a
central reader) or development of a new or re-draining fistula
or abscess, before or at week 76. Endoscopic recurrence was
a major secondary end point. RESULTS: A smaller proportion
of patients in the infliximab group had a clinical recurrence
before or at week 76 compared with the placebo group, but
this difference was not statistically significant (12.9% vs
20.0%; absolute risk reduction [ARR] with infliximab, 7.1%;
95% confidence interval: 1.3% to 15.5%; P \ubc .097). A
significantly smaller proportion of patients in the infliximab
group had endoscopic recurrence compared with the placebo
group (30.6% vs 60.0%; ARR with infliximab, 29.4%; 95%
confidence interval: 18.6% to 40.2%; P < .001). Additionally,
a significantly smaller proportion of patients in the infliximab
group had endoscopic recurrence based only on Rutgeerts
scores i2 (22.4% vs 51.3%; ARR with infliximab,
28.9%; 95% confidence interval: 18.4% to 39.4%; P < .001).
Patients previously treated with anti-tumor necrosis factor
agents or those with more than 1 resection were at greater
risk for clinical recurrence. The safety profile of infliximab
was similar to that from previous reports. CONCLUSIONS:
Infliximab is not superior to placebo in preventing clinical
recurrence after CD-related resection. However, infliximab
does reduce endoscopic recurrence
Firefly: The Case for a Holistic Understanding of the Global Structure and Dynamics of the Sun and the Heliosphere
This white paper is on the HMCS Firefly mission concept study. Firefly focuses on the global structure and dynamics of the Sun's interior, the generation of solar magnetic fields, the deciphering of the solar cycle, the conditions leading to the explosive activity, and the structure and dynamics of the corona as it drives the heliosphere